Kenneth J Kellar

This inventor holds 12 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Georgetown University, Duke University, Johns Hopkins University. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth J Kellar. Retrieved from https://idiyas.com/inventor/kenneth-j-kellar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 58.3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 28(Granted Patents)

Location History:

Potomac, MD (US) (2014)
Bethesda, MD (US) (2002 - 2022)

Company Filing History:

11 out of 499

Georgetown University

Johns Hopkins University

patents

4. 1 out of 2

Potomac Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11278522 - Use of methadone metabolites for treatment of anxiety and depression (2022-03-22),

2. 10709685 - Use of methadone metabolites for treatment of anxiety and depression (2020-07-14),

3. 10407406 - 2-halo-5-alkynyl-pyridyl nicotinic ligands (2019-09-10),

4. 9994548 - Phenyl-substituted nicotinic ligands, and methods of use thereof (2018-06-12),

5. 9993465 - 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof (2018-06-12),

6. 9890137 - 2-halo-5-alkynyl-pyridyl nicotinic ligands (2018-02-13),

7. 9346784 - Phenyl-substituted nicotinic ligands, and methods of use thereof (2016-05-24),

8. 9303017 - 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof (2016-04-05),

9. 8729103 - Silent desensitizers of neuronal nAChR and methods of use thereof (2014-05-20),

10. 8642612 - Nicotinic desensitizers and methods of selecting, testing, and using them (2014-02-04),

11. 8030300 - Ligands for nicotinic acetylcholine receptors, and methods of making and using them (2011-10-04),

12. 6369052 - Combination of huperzine and nicotinic compounds as a neuroprotective agent (2002-04-09),

Title: The Innovative Journey of Kenneth J. Kellar

Introduction: Kenneth J. Kellar, a distinguished inventor based in Bethesda, MD, has made significant contributions to the field of technology and innovation.

Latest Patents: Kenneth J. Kellar holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Kenneth J. Kellar has been at the forefront of innovation, leading groundbreaking projects and developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Kenneth J. Kellar has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the field.

Conclusion: Kenneth J. Kellar's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor, shaping the future of technology and inspiring generations to come.

Profile summary based on public USPTO records.